Wei Jin-Tao, Huang Wen-He, Du Cai-Wen, Qiu Si-Qi, Wei Xiao-Long, Liu Jing, Zhang Guo-Jun
1] The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou 515041, China [2] [3].
1] The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou 515041, China [2].
Sci Rep. 2014 Jun 19;4:5360. doi: 10.1038/srep05360.
Breast cancer in young women is typically with higher proportion of adverse pathological features. Breast cancer with BRCA1 mutation is often early-onset, and is usually associated with triple negative phenotpe. In this study, we aim to analyze the clinicopathological characteristics and prognosis in young breast cancer patients (≤35 years old) comparing to non-young patients (>35 years old). A total of 1913 cases of primary breast carcinoma with stage I-III were enrolled, with 283 cases diagnosed as young patients. No significant difference was observed in tumor size, TNM staging, lymph node metastasis, ER, HER-2 or histological grade between young and non-young patients. Multivariate analysis demonstrated that age was an independent prognostic factor for overall survival (OS). In 70 samples of young patients available, BRCA1 was immunohistochemically positive 85.7% in cytoplasm and 41.4% in nuclear. BRCA1 nuclear expression is not significantly associated with clinicopathological characteristics in young breast cancer patients.
年轻女性乳腺癌通常具有较高比例的不良病理特征。携带BRCA1突变的乳腺癌往往发病较早,且通常与三阴性表型相关。在本研究中,我们旨在分析年轻乳腺癌患者(≤35岁)与非年轻患者(>35岁)相比的临床病理特征及预后。共纳入1913例I-III期原发性乳腺癌病例,其中283例被诊断为年轻患者。年轻患者与非年轻患者在肿瘤大小、TNM分期、淋巴结转移、雌激素受体(ER)、人表皮生长因子受体2(HER-2)或组织学分级方面未观察到显著差异。多因素分析表明,年龄是总生存期(OS)的独立预后因素。在70例可获得的年轻患者样本中,BRCA1免疫组化在细胞质中的阳性率为85.7%,在细胞核中的阳性率为41.4%。BRCA1在细胞核中的表达与年轻乳腺癌患者的临床病理特征无显著相关性。